Trump Considers Medicare GLP-1 Coverage, Bearish Signal for $HIMS Investors
Key Takeaways Reports suggest a potential US government pilot to extend Medicare and Medicaid coverage to GLP-1 weight-loss drugs, a policy that could significantly alter market dynamics. Such a move...